王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医学科学院北京协和医学院
• 2:中国医学科学院北京协和医学院北京协和医院内分泌科国家卫健委内分泌重点实验室

摘要(Abstract)：

新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)已成为危及全球的传染性疾病,重症患者死亡风险极高。临床研究显示,肥胖症是COVID-19患者发生重症及死亡的独立危险因素。对于合并肥胖症的COVID-19患者,应尽早评估肥胖相关合并症,并在营养、气道管理、抗凝、合并症控制等方面采取更积极的干预措施,以改善预后。
The pandemic of coronavirus disease 2019(COVID-19) has spread worldwide and the mortality is high in severe COVID-19 patients. Clinical studies suggested that obesity is an independent risk factor for severe and dead cases of COVID-19. For COVID-19 patients with obesity, early evaluation of obesity-related comorbidities and aggressive treatments, including diet control, airway management, anticoagulant thromboprophylaxis, and management of comorbidities, are encouraged to improve their prognosis.

关键词(KeyWords)： 新型冠状病毒肺炎;肥胖症;评估;治疗
coronavirus disease 2019;obesity;evaluation;treatment

Abstract:

Keywords:

基金项目(Foundation): 中国医学科学院医学与健康科技创新工程(2016-I2M-1-002)~~

作者(Author): 王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1] Guan WJ,Ni ZY,Hu Y,et al.Clinical Characteristics of Coronavirus Disease 2019 in China[J].N Engl J Med,2020,382:1708- 1720.
• [2] Global Health Obsevatory (GHO) data:overweight and obesity[EB/OL].https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
• [3] Huang Y,Lu Y,Huang YM,et al.Obesity in patients with COVID- 19:a systematic review and meta-analysis[J].Metabolism,2020,113:154378.
• [4] Hussain A,Mahawar K,Xia Z,et al.Obesity and mortality of COVID- 19.Meta-analysis[J].Obes Res Clin Pract,2020,14:295- 300.
• [5] Du Y,Lv Y,Zha W,et al.Association of Body mass index (BMI) with Critical COVID- 19 and in-hospital Mortality:a dose-response meta-analysis[J].Metabolism,2020.doi:10.1016/j.metabol.2020.154373:154373.
• [6] Cai Q,Chen F,Wang T,et al.Obesity and COVID- 19 Severity in a Designated Hospital in Shenzhen,China[J].Diabetes Care,2020,43:1392- 1398.
• [7] Soeroto AY,Soetedjo NN,Purwiga A,et al.Effect of increased BMI and obesity on the outcome of COVID- 19 adult patients:A systematic review and meta-analysis[J].Diabetes Metab Syndr,2020,14:1897- 1904.
• [8] F?ldi M,Farkas N,Kiss S,et al.Obesity is a risk factor for developing critical condition in COVID- 19 patients:A systematic review and meta-analysis[J].Obes Rev,2020,21:e13095.
• [9] Seidu S,Gillies C,Zaccardi F,et al.The impact of obesity on severe disease and mortality in people with SARS-CoV- 2:A systematic review and meta-analysis[J].Endocrinol Diabetes Metab,2020.doi:10.1002/edm2.176:e00176.
• [10] Sattar N,McInnes IB,McMurray JJV.Obesity Is a Risk Factor for Severe COVID- 19 Infection:Multiple Potential Mechanisms[J].Circulation,2020,142:4- 6.
• [11] Nakeshbandi M,Maini R,Daniel P,et al.The impact of obesity on COVID- 19 complications:a retrospective cohort study[J].Int J Obes (Lond),2020,44:1832- 1837.
• [12] Tsuriya D,Morita H,Morioka T,et al.Significant correla-tion between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects[J].Intern Med,2011,50:2767- 2773.
• [13] Noor FM,Islam MM.Prevalence and Associated Risk Factors of Mortality Among COVID- 19 Patients:A Meta-Analysis[J].J Community Health,2020,45:1270- 1282.
• [14] Chen C,Lu FC.The guidelines for prevention and control of overweight and obesity in Chinese adults[J].Biomed Environ Sci,2004,17 Suppl:1- 36.
• [15] Tchernof A,Després JP.Pathophysiology of human visceral obesity:an update[J].Physiol Rev,2013,93:359- 404.
• [16] Sharma AM,Kushner RF.A proposed clinical staging system for obesity[J].Int J Obes (Lond),2009,33:289- 295.
• [17] Petersen A,Bressem K,Albrecht J,et al.The role of visceral adiposity in the severity of COVID- 19:Highlights from a unicenter cross-sectional pilot study in Germany[J].Metabolism,2020,110:154317.
• [18] Chiappetta S,Sharma AM,Bottino V,et al.COVID- 19 and the role of chronic inflammation in patients with obesity[J].Int J Obes (Lond),2020,44:1790- 1792.
• [19] Ye Q,Wang B,Mao J.The pathogenesis and treatment of the `Cytokine Storm' in COVID- 19[J].J Infect,2020,80:607- 613.
• [20] Watanabe M,Caruso D,Tuccinardi D,et al.Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID- 19[J].Metabolism,2020,111:154319.
• [21] Yang Y,Ding L,Zou X,et al.Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV- 2[J].Obesity (Silver Spring),2020,28:2040- 2048.
• [22] Dixon AE,Peters U.The effect of obesity on lung function[J].Expert Rev Respir Med,2018,12:755- 767.
• [23] Memtsoudis SG,Ivascu NS,Pryor KO,et al.Obesity as a risk factor for poor outcome in COVID- 19-induced lung injury:the potential role of undiagnosed obstructive sleep apnoea[J].Br J Anaesth,2020,125:e262-e263.
• [24] Guo T,Fan Y,Chen M,et al.Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID- 19)[J].JAMA Cardiol,2020,5:811- 818.
• [25] Shi S,Qin M,Shen B,et al.Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID- 19 in Wuhan,China[J].JAMA Cardiol,2020,5:802- 810.
• [26] Ghoneim S,Butt MU,Hamid O,et al.The incidence of COVID- 19 in patients with metabolic syndrome and non-alcoholic steatohepatitis:A population-based study[J].Metabol Open,2020,8:100057.
• [27] Iqbal Z,Ho JH,Adam S,et al.Managing hyperlipidaemia in patients with COVID- 19 and during its pandemic:An expert panel position statement from HEART UK[J].Atherosclerosis,2020,313:126- 136.
• [28] Fernández García L,Puentes Gutiérrez AB,García Bascones M.Relationship between obesity,diabetes and ICU admis-sion in COVID- 19 patients[J].Med Clin (Engl Ed),2020,155:314- 315.
• [29] Ochoa JB,Cárdenas D,Goiburu ME,et al.Lessons Learned in Nutrition Therapy in Patients With Severe COVID- 19[J].JPEN J Parenter Enteral Nutr,2020,44:1369- 1375.
• [30] Helms J,Tacquard C,Severac F,et al.High risk of thrombosis in patients with severe SARS-CoV- 2 infection:a multicenter prospective cohort study[J].Intensive Care Med,2020,46:1089- 1098.
• [31] Moores LK,Tritschler T,Brosnahan S,et al.Prevention,Diagnosis,and Treatment of VTE in Patients With Coronavirus Disease 2019:CHEST Guideline and Expert Panel Report[J].Chest,2020,158:1143- 1163.
• [32] Mauvais-Jarvis F.Aging,Male Sex,Obesity,and Metabolic Inflammation Create the Perfect Storm for COVID- 19[J].Diabetes,2020,69:1857- 1863.
• [33] Bornstein SR,Rubino F,Khunti K,et al.Practical recommendations for the management of diabetes in patients with COVID- 19[J].Lancet Diabetes Endocrinol,2020,8:546- 550.
• [34] Roche provides an update on the phase Ⅲ COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID- 19 associated pneumonia[EB/OL].(2020- 07- 29).https://www.roche.com/investors/updates/inv-update- 2020- 07- 29.htm.
• [35] Huang JF,Wang XB,Zheng KI,et al.Letter to the Editor:Obesity hypoventilation syndrome and severe COVID-19[J].Metabolism,2020,108:154249.
• [36] Singer P,Blaser AR,Berger MM,et al.ESPEN guideline on clinical nutrition in the intensive care unit[J].Clin Nutr,2019,38:48- 79.
• [37] Wijaya I,Andhika R,Huang I.Hypercoagulable state in COVID- 19 with diabetes mellitus and obesity:Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?[J].Diabetes Metab Syndr,2020,14:1241- 1242.
• [38] Susen S,Tacquard CA,Godon A,et al.Prevention of thrombotic risk in hospitalized patients with COVID- 19 and hemostasis monitoring[J].Critical Care,2020,24:364.
• [39] Marini JJ,Gattinoni L.Management of COVID-19 Respira-tory Distress[J].JAMA,2020,323:2329- 2330.
• [40] De Jong A,Wrigge H,Hedenstierna G,et al.How to ventilate obese patients in the ICU[J].Intensive Care Med,2020,46:2423- 2435.
• [41] Lemyze M,Courageux N,Maladobry T,et al.Implications of Obesity for the Management of Severe Coronavirus Disease 2019 Pneumonia[J].Crit Care Med,2020,48:e761-e767.
• [42] Moriconi D,Masi S,Rebelos E,et al.Obesity prolongs the hospital stay in patients affected by COVID- 19,and may impact on SARS-COV- 2 shedding[J].Obes Res Clin Pract,2020,14:205- 209.
• [43] Katulanda P,Dissanayake HA,Ranathunga I,et al.Prevention and management of COVID- 19 among patients with diabetes:an appraisal of the literature[J].Diabetologia,2020,63:1440- 1452.